Stoke Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Stoke Therapeutics (Nasdaq: STOK) announced that CEO Edward M. Kaye, M.D., will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 4:30 p.m. ET. The company specializes in addressing the underlying causes of genetic diseases by upregulating protein expression. A live audio webcast of the presentation will be available on Stoke’s Investors & Media page, with a replay accessible for 30 days post-event. Stoke aims to innovate treatment for autosomal dominant haploinsufficiencies, restoring essential protein levels for better health outcomes.

Stoke Therapeutics, Inc., (Nasdaq: STOK), a clinical-stage biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the 39^th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 4:30 p.m. ET.

A live audio webcast of the presentation will be available on the Investors & Media section of Stoke’s website at https://investor.stoketherapeutics.com/. A replay of the webcast will be available for 30 days following the presentations.

About Stoke Therapeutics

Stoke Therapeutics (Nasdaq: STOK), is a clinical-stage biotechnology company pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50% of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ or follow the company on Twitter at @StokeTx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005747/en/

FAQ

What is the date and time of Stoke Therapeutics' presentation at the J.P. Morgan Healthcare Conference?

Stoke Therapeutics will present at the J.P. Morgan Healthcare Conference on January 11, 2021, at 4:30 p.m. ET.

Where can I watch Stoke Therapeutics' presentation at the J.P. Morgan Healthcare Conference?

You can watch Stoke Therapeutics' presentation live on their Investors & Media section of their website.

What is Stoke Therapeutics' focus in the biotechnology field?

Stoke Therapeutics focuses on developing treatments for genetic diseases by precisely upregulating protein expression.

What is the stock symbol for Stoke Therapeutics?

The stock symbol for Stoke Therapeutics is STOK.

How long will the webcast replay of Stoke's presentation be available?

The replay of Stoke Therapeutics' presentation will be available for 30 days following the event.